What diagnoses and medications should be avoided when prescribing promethazine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Promethazine: Contraindications and Drug Interactions

Promethazine is absolutely contraindicated in children under 2 years of age due to fatal respiratory depression risk, and must be avoided with CNS depressants, epinephrine, and in patients with narrow-angle glaucoma, prostatic hypertrophy, or compromised respiratory function. 1

Absolute Contraindications by Age and Respiratory Status

  • Children under 2 years old: Promethazine is contraindicated due to postmarketing reports of fatal respiratory depression, which occurs independent of weight-based dosing. 1
  • Children 2 years and older: Use only the lowest effective dose and avoid all concomitant respiratory depressants. 1
  • Compromised respiratory function: Avoid promethazine entirely in patients with COPD or sleep apnea, as it may lead to potentially fatal respiratory depression. 1

Critical Drug Interactions Requiring Avoidance or Dose Reduction

CNS Depressants (Reduce or Avoid)

  • Barbiturates: Reduce barbiturate dose by at least one-half when co-administered with promethazine. 1
  • Narcotics/opioids: Reduce narcotic dose by one-quarter to one-half to prevent excessive sedation and respiratory depression. 1
  • Other CNS depressants: Alcohol, sedatives/hypnotics, narcotic analgesics, general anesthetics, tricyclic antidepressants, and tranquilizers should be eliminated or given in reduced dosage. 1
  • Pediatric patients: Concomitant respiratory depressants are strongly associated with death in children and must be avoided. 1

Epinephrine (Absolute Avoidance)

  • Do NOT use epinephrine to treat promethazine-associated hypotension: Promethazine reverses epinephrine's vasopressor effect, potentially worsening hypotension. 1

MAO Inhibitors (Use with Caution)

  • Increased extrapyramidal effects: Drug interactions, including heightened extrapyramidal symptoms, have been reported when MAOIs and phenothiazines are used together. 1

Anticholinergic Agents (Use with Caution)

  • Additive anticholinergic effects: Concomitant use of other anticholinergic agents should be undertaken with caution due to cumulative effects. 1

Medical Conditions Requiring Avoidance or Extreme Caution

Anticholinergic-Sensitive Conditions (Use with Caution)

  • Narrow-angle glaucoma: Anticholinergic properties may precipitate acute angle closure. 1
  • Prostatic hypertrophy: Risk of urinary retention increases significantly. 2, 1
  • Bladder-neck obstruction: Anticholinergic effects worsen obstruction. 1
  • Stenosing peptic ulcer or pyloroduodenal obstruction: Anticholinergic effects may exacerbate obstruction. 1
  • Elevated intraocular pressure: Anticholinergic properties contraindicate use. 2

Neurological Conditions

  • Seizure disorders: Promethazine lowers seizure threshold and should be used with caution, especially when combined with narcotics or local anesthetics that also affect seizure threshold. 1
  • Existing cognitive impairment: Elderly patients and those with baseline cognitive deficits face higher risk of worsening impairment, anticholinergic side effects, and falls. 2

Hematologic Conditions

  • Bone marrow depression: Use with caution; leukopenia and agranulocytosis have been reported, particularly when combined with other marrow-toxic agents. 1

Cardiovascular Conditions

  • Cardiovascular disease: Use cautiously due to hypotension risk and QT prolongation potential. 1, 3
  • QT prolongation risk: Promethazine directly blocks hERG K+ channels, which can lead to torsades de pointes. 3

Hepatic Impairment

  • Liver dysfunction: Use cautiously in patients with impaired liver function. 1

Special Population Warnings

Pregnancy and Labor

  • Pregnancy Category C: Use only if potential benefit justifies fetal risk; teratogenic effects have not been demonstrated in rats, but fetal mortality occurred at high doses. 1
  • Within 2 weeks of delivery: May inhibit platelet aggregation in the newborn. 1

Elderly Patients

  • Higher risk population: Increased likelihood of cognitive impairment, anticholinergic side effects, and falls. 2

Serious Adverse Reactions Requiring Monitoring

Extrapyramidal Effects

  • Monitor for dystonia, akathisia, restlessness, and oculogyric crises: Have diphenhydramine 25-50 mg readily available for prompt treatment. 4, 2
  • Neuroleptic malignant syndrome: A potentially fatal syndrome characterized by hyperpyrexia, muscle rigidity, altered mental status, and autonomic instability; discontinue promethazine immediately if suspected. 1

Tissue Damage (IV Administration)

  • Thrombophlebitis, tissue necrosis, and gangrene: Can occur with extravasation or inadvertent intra-arterial injection; infuse slowly (≤25 mg/min) and avoid repeated or prolonged IV courses. 2, 5, 6

Common Pitfalls to Avoid

  • Inappropriate use for uncomplicated vomiting in children: Antiemetics are not recommended for simple vomiting in pediatric patients; reserve for prolonged vomiting of known etiology. 1
  • Chronic use for insomnia: Promethazine has no good evidence base for sleep, impedes cognitive-behavioral therapy effectiveness, has addictive potential, and an unacceptable side-effect profile for psychiatric patients. 7
  • Excessive promethazine relative to narcotics: May lead to restlessness and motor hyperactivity in patients with pain. 1

References

2
Guideline

Promethazine Prescription Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4
Guideline

aga institute review of endoscopic sedation.

Gastroenterology, 2007

5
Guideline

Promethazine Intravenous Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

6
Research

Promethazine: A Review of Therapeutic Uses and Toxicity.

The Journal of emergency medicine, 2024

Related Questions

What is the recommended oral syrup dose of promethazine (Phenergan) for children, including age and weight criteria, concentration, dosing interval, and maximum dose?
Is there a drug‑drug interaction between promethazine and potassium, and should serum potassium be monitored or supplemented when prescribing promethazine?
Is promethazine appropriate for treating a cough?
Does promethazine possess antispasmodic properties?
What dose of promethazine syrup (available as 6.25 mg per 5 mL or 15 mg per 5 mL) should be given to a child weighing 8.23 kg?
Is it safe for a patient wearing a rigid or semi‑rigid cervical collar (and taking analgesics or muscle relaxants) to drive?
Which antibiotics are recommended for Shiga toxin‑producing Escherichia coli infection?
Can intranasal mometasone furoate cause hypertension in otherwise healthy adults?
Why is azithromycin contraindicated in infants under two months of age?
What is CANVAS syndrome (Cerebellar Ataxia, Neuropathy and Vestibular Areflexia Syndrome) and how is it diagnosed and managed?
How well does aztreonam penetrate the cerebrospinal fluid in an adult with suspected Gram‑negative meningitis, and what is the appropriate meningitis dosing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.